Intact Therapeutics
Phase 1Develops targeted immunotherapies for cancer using proprietary platforms to enhance T-cell activation and tumor infiltration.
Founded
2018
Focus
OncologyImmunology
About
Develops targeted immunotherapies for cancer using proprietary platforms to enhance T-cell activation and tumor infiltration.
Funding History
2Total raised: $5M
Grant$2MNIH SBIRNov 15, 2021
Seed$3MUndisclosedMay 15, 2020
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile